| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10919974 | Radiotherapy and Oncology | 2005 | 8 Pages |
Abstract
Delaying RT jeopardizes survival even after intensive chemotherapy. Predominant site of failure is the primary tumor site. RT of the neuraxis should be omitted in localized disease.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Beate Timmermann, Rolf-Dieter Kortmann, Joachim Kühl, Stefan Rutkowski, Karin Dieckmann, Christof Meisner, Michael Bamberg,